Robert L. Hitchcock, Managing Partner
Phone: 650-327-9710 / 650-868-0288
Email: bob@trgba.com
Bob began his career in sales with IBM in San Francisco followed by increasingly responsible sales management positions in Toronto and Los Angeles. From IBM Bob was recruited to lead sales and marketing operations for the Computer Products Division of Ampex Corporation (A Fortune 500 company). Under Bob’s leadership, the division grew from $75 million to $122 million in sales over a two-year period.
In the 1980’s Bob led the sales and marketing operation of Navteq, the world leader in computer navigation systems and also directed international sales and marketing operations for The Complete PC, an industry leading computer peripherals company. Bob established and built their OEM operation and expanded their international operation into 10 new major European and Asian markets.
In the 90’s Bob was President and CEO of Datavision Technologies, a one-to-one direct marketing company that developed and patented the process of delivering customized video and audio presentations for interactive television and the Internet. Under Bob’s guidance the company created and launched a professional services product for the education market that became an industry standard and was named product of the year. Additionally the company developed personalized direct marketing programs for multiple major corporations such as Lexus, American Express, and The Disney Company. In 1999 it was successfully sold to an east coast direct marketing firm.
Bob is the Managing Partner of The Results Group and is directly involved and the key point person in every client relationship.
Bob’s clients have included both privately funded companies and publicly traded corporations. The firm works on a nationwide basis with particular emphasis on the western United States.
Bob has a BS in marketing from the University of Oregon and an MBA with honors in international business from the Thunderbird Graduate School of International Management.
Wendy R. Hitchcock, Consulting Partner
Phone: 650-327-9710 / 650-858-0287
Email: wendy.hitchcock@gmail.com
Wendy Hitchcock has successfully led critical growth transitions for life science technology and information companies, focusing on building sustainable value through strategic alliance, financing and market initiatives.
In addition to being a consulting partner to The Results Group, Ms. Hitchcock is the Chief Executive Officer and a member of the Board of Trustees of Vascular Cures (vascularcures.org), a non-profit medical organization dedicated to accelerating research into the cause, prevention and treatment of vascular disease.
Ms. Hitchcock is also a member of the Board of Directors of Mercator Medsystems (mercatormed.com) and was the Chief Business Officer and Executive Vice President of the firm. Mercator Medsystems is a medical device company that has developed a catheter based micro syringe that enables site specific drug delivery anywhere in the body.
Prior to Mercator Ms. Hitchcock was CEO of LabVelocity, which was sold to Infotrieve Inc., a global information provider to scientific and technology customers. LabVelocity provides structured content and search technology to improve R&D decision-making for bio-pharma and its scientists, maximize yield on research spending and increase sales for manufacturers of research products.
Prior to LabVelocity, Ms. Hitchcock was interim SVP of Operations for Affymax following an investor buyout from GlaxoSmithKline in 2001. She managed all the business, organizational and legal aspects of its transition from a pharmaceutical research unit of GSK into a privately held independent company. Affymax successfully completed its IPO in December, 2006.
She joined ACLARA BioSciences, a life science tools/technology company in 1999 as Chief Financial Officer, and led its IPO in 2000. Prior to this Ms. Hitchcock completed a strategic acquisition as VP corporate development for a public ophthalmic device company, and was Chief Financial Officer for SyStemix, a stem cell and gene therapy company, from 1993 through its acquisition by Novartis in 1997.
Prior to 1993 Wendy was CEO of a private investment company and Practice Leader launching a new venture within a public consulting and accounting firm. She has a B.A. with honors from Brown University and an MBA, Finance with honors from the University of California at Los Angeles.
Eric Lium, Ph.D., Consulting Partner - Life Sciences
Phone: 650-8989468
Email: eklium@gmail.com
Dr. Lium has 19 years of combined experience in life science and information service business and academic science with demonstrated success in founding, building and financing a venture-backed company, business development, enterprise sales, and market strategy.
In addition to being a Consulting Partner to The Results Group, Inc. Dr. Lium is the Director of Industry Contracts Division, Office of Sponsor Research at the University of California, San Francisco. Dr. Lium is directly responsible for integrating UCSF Global Heath Sciences expertise in all of the health, social, and biological sciences, and focuses that expertise on pressing issues in global health.
Prior to UCSF, Dr. Lium completed the sale of LabVelocity Inc., an information services company focused on accelerating life science R&D processes, to Infotrieve Inc. Dr. Lium served as Director of Integrated Product Solutions at Infotrieve where he played central roles in post-acquisition integration, and the expansion of Infotrieve product offerings in the life sciences market.
While at LabVelocity, Dr. Lium served as President and a member of the Board of Directors, and lead diverse initiatives in corporate development, financing and business development. Prior to co-founding LabVelocity, Dr. Lium served as a postdoctoral research scientist in the G.W. Hooper Foundation at the University of California, San Francisco. Dr. Lium received his Ph.D. with honors from Columbia University where his work was focused on Herpes Simplex Virus Type-1 gene expression and infection.
Dr. Lium has authored or co-authored seven peer-reviewed articles published in recognized scientific journals, and holds one patent on the use of cobalt chelates to inhibit Herpes and other virus infections.